ACM
ZBH icon

Armbruster Capital Management’s Zimmer Biomet ZBH Stock Holding History

Armbruster Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-946
Closed -$100K – 205
2018
Q1 		$100K Hold
946
– – 0.05% 95
2017
Q4 		$111K Sell
946
-2
-0.2% -$226 0.05% 93
2017
Q3 		$108K Hold
948
– – 0.06% 91
2017
Q2 		$118K Hold
948
– – 0.06% 90
2017
Q1 		$112K Sell
948
-51
-5% -$5.78K 0.06% 92
2016
Q4 		$100K Hold
999
– – 0.06% 96
2016
Q3 		$127K Hold
999
– – 0.08% 83
2016
Q2 		$117K Hold
999
– – 0.08% 87
2016
Q1 		$103K Hold
999
– – 0.07% 91
2015
Q4 		$100K Buy
+999
New +$97.7K 0.09% 91

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Armbruster Capital Management's ZBH Position: Q2 2018 in Review

Armbruster Capital Management sold out of Zimmer Biomet (ZBH) in Q2 2018, closing a stake of 946 shares — an estimated $100K sold.

Armbruster Capital Management first reported a position in ZBH in Q4 2015 and held it in 10 quarters. The position peaked at $127K in Q3 2016. 869 funds tracked by Wall St. Rank hold ZBH as of Q2 2018.

  • Armbruster Capital Management reported no remaining Zimmer Biomet position as of Q2 2018 after selling out during the quarter.
  • Armbruster Capital Management sold 946 Zimmer Biomet shares in Q2 2018, an estimated $100K.
  • Armbruster Capital Management first reported a position in Zimmer Biomet in Q4 2015 and held it in 10 quarters.
  • Armbruster Capital Management's Zimmer Biomet position peaked at $127K in Q3 2016.
  • 869 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2018.

Based on Armbruster Capital Management's 13F filing for Q2 2018, filed 30 Jul 2018.